Skip to content
IPO Candy
  • Home
  • About
  • SPAC IPOs
  • Spinoffs
  • Contact Us
  • Log in
  • Subscribe
  • Latest
  • Consumer
  • Energy
  • Finance
  • Healthcare
  • MicroCap Candy
  • Research
  • Technology

Mineralys Therapeutics (MLYS) IPO deck

Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone.

Debarshi Ghosh
6 Feb 2023
  • Share on Twitter
  • Share on Facebook
  • Share on LinkedIn
  • Share on Pinterest
  • Share via Email
  • Copy link

This post is for subscribers only

Subscribe now

Already have an account? Sign in

This post is for subscribers only

Subscribe

Already have an account? Log in


You might also like

Schrodinger's platform for accelerated drug development and materials discovery Paid Members Public

Kris Tuttle
5 Feb 2020
Featured

Syndax IPO reboot may help the fight against cancer tumors Paid Members Public

Kris Tuttle
1 Mar 2016
Healthcare

IPO Candy Newsletter

Join the newsletter to receive the latest updates in your inbox.

Please check your inbox and click the link to confirm your subscription.
Please enter a valid email address!
An error occurred, please try again later.
  • Twitter
  • Facebook
  • RSS

Featured Posts

MicroCap Candy Roundup

8 Mar 2023

Closing $NXT Coverage Swing

6 Mar 2023

Nextracker $NXT Sunny Debut

15 Feb 2023

Posted Decks January 2023

6 Feb 2023

Vox Royalty $VOXR

23 Jan 2023

Authors →

Kris Tuttle

Debarshi Ghosh

IPO Candy

New companies in the public markets.

Navigation

  • Sign up

Newsletter

Please check your inbox and click the link to confirm your subscription.
Please enter a valid email address!
An error occurred, please try again later.
© 2023 IPO Candy - Published with Ghost & Krabi